From discovery to distribution, Unigen is dedicated to the development of botanical and marine-derived therapeutic compounds that address consumer health needs and improve quality of life. Established in 1996, our research and discovery process includes extensive testing at the genetic, cellular, and human clinical levels.
Unigen is a global leader in the discovery and development of proprietary natural ingredients for the dietary supplement, food, cosmetics, personal care and pharmaceutical industries. With a core of scientifically substantiated natural ingredients already distribute worldwide, we continue to push the boundaries of pharmaceutical quality research and novel applications for natural products.
The company has one of the most extensive medicinal plant collections in the world and utilizes a state-of-the-art pharmaceutical discovery approach to identify the most safe and effective botanically-based proprietary ingredients. The efficacy of Unigen’s natural product ingredients is established through human clinical trials, and unlike synthetic drugs, Unigen’s natural substances have a legacy of safe human consumption without the undesirable side-effects that limit the use of pharmaceuticals. Unigen protects its discoveries through patents and commercializes its products through alliances with partners that possess distribution and marketing capabilities in each of Unigen’s target markets.
-
Industry
-
Biotechnology Research
-
Company size
-
51-200 employees
-
Headquarters
-
Tacoma, WA
-
Type
-
Privately Held
-
Specialties
-
Research & Development, Proprietary PhytoLogix platform, and Patented novel raw ingredients
